Monitoring glucose levels in critically ill patients
Official title: Continuous Subcutaneous Glucose Monitoring: A Descriptive Study of Its Use in Critical Patients
Run by Universidad Europea de Madrid · NCT06234787 · Data updated 2026-11-12
This study looks at how often critically ill patients in the ICU experience low blood sugar and how using continuous glucose monitors can help improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 245 (estimated) |
| Sponsor | Universidad Europea de Madrid Academic / other |
| Locations | 1 site (Madrid) |
| Status | Recruiting |
| Started | November 30, 2023 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | February 5, 2024 |
| Trial ID | NCT06234787 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include critically ill patients in the ICU who are undergoing insulin treatment and have a CGM sensor.
✕Probably not a fit
Patients who are not admitted to the ICU or those who cannot provide information on CGM due to technical issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the incidence of hypoglycemic events in critically ill patients admitted to the ICU at HLA Moncloa Hospital over a four-year period. It will document occurrences of low glucose levels detected by continuous subcutaneous glucose monitoring (CGM) and describe the characteristics of patients receiving CGM sensors. The study seeks to understand the impact of glycemic control on patient outcomes and the actions taken in response to detected hypoglycemic events.
Why it matters
Potential benefit: If successful, this study could improve glycemic management in critically ill patients, potentially reducing the incidence of hypoglycemic events and associated complications.
How similar studies have gone: Other studies have shown varying success with continuous glucose monitoring in critical care settings, indicating potential benefits but also highlighting the complexity of glycemic management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The study will be conducted in patients admitted to the ICU of HLA Moncloa Hospital over four years. Patients admitted to the ICU, undergoing insulin treatment, and having a CGM sensor. * Patients who sign the voluntary consent to participate in the study (Annex 2). If the participant is not in full physical or intellectual capacity to provide their signature on the informed consent, the responsible investigator will request such consent from their direct family member or the person legally designated to make decisions on their behalf regarding health matters. This measure is taken to ensure that the participant\'s rights are respected, and the integrity of the consent process is maintained, even in situations where their decision-making capacity may be compromised. Exclusion Criteria: * Patients from whom information on CGM cannot be obtained for technical reasons.
Where it's running
-
Hospital Universitario HLA Moncloa
Madrid, Spain Recruiting
Study contacts
- Study coordinator: Samuel G González, Doctor
- Email: samuelgonlop@gmail.com
- Phone: 34692619904
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Breath sensor for detecting hypo- and hyperglycemia in teens with type 1 diabetes
This test checks whether a breath-based VOC sensor can spot low or high blood sugar in 12–19-year-olds with type 1 diabetes who use a Dexcom CGM.
-
Improving diabetes management in hospitals with a decision support tool
This study is testing a new electronic tool that helps doctors manage blood sugar levels in hospitalized patients with diabetes to see if it improves their care and reduces costs.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Using continuous glucose monitoring for newborns with brain injury
This study is testing if using continuous glucose monitoring can help newborns with brain injury keep their blood sugar levels stable and improve their health outcomes.
-
Understanding blood sugar control in patients with Left Ventricular Assist Devices
This study is trying to see if using a continuous glucose monitor gives better information about blood sugar control than traditional blood tests for people with Left Ventricular Assist Devices and type 2 diabetes.
-
Using semaglutide to manage high blood sugar after kidney transplants
This study is testing if semaglutide can help manage high blood sugar in people who have recently had a kidney transplant, while also looking at its effects on weight and kidney function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.